Funders › FL › Ambers Antibodies Inc › 2022
Grants paid by Ambers Antibodies Inc, tax year 2022
EIN 45-4170094 · Naples, FL · Form 990-PF, Part XV · NTEE T70
In tax year 2022, Ambers Antibodies Inc (EIN 45-4170094) reported 7 grants paid totaling $26,055. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2022
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2022 | American Cancer Society Atlanta, GA | U | $20,000 | paid | RESEARCH GRANT | 202343199349105724 |
| 2022 | Colorectal Cancer Alliance Washington, DC | B | $1,055 | paid | RESEARCH GRANT | 202343199349105724 |
| 2022 | Emily Rose Empwr Foundation Odessa, FL | B | $1,000 | paid | RESEARCH GRANT | 202343199349105724 |
| 2022 | Sarcoma Foundation of America Damascus, MD | C | $1,000 | paid | RESEARCH GRANT | 202343199349105724 |
| 2022 | Cheering for Breanna Foundation Prairieville, LA | B | $1,000 | paid | RESEARCH GRANT | 202343199349105724 |
| 2022 | Cancer Kicks Inc Marietta, GA | D | $1,000 | paid | RESEARCH GRANT | 202343199349105724 |
| 2022 | The Regents of University of Michigan Ann Arbor, MI | D | $1,000 | paid | RESEARCH GRANT | 202343199349105724 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.